🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of the present study is to evaluate the best regimen for inflixima...
Status
Terminated
Location
The E. Wolfson.Medical Center
Start Date
2013-02
Trial ID
NCT01802593
Treatments Being Tested
RATIONALE: Bone marrow transplantation may be able to replace immune cells ...
Status
Completed
Location
Dana-Farber Cancer Institute
Start Date
2000-02
Trial ID
NCT00005988
The goal of this study is to implement instruments that would increase the ...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00748826
Treatments Being Tested
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
The purpose of this study is to determine the response and toxicity rate of...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2022-01-01
Trial ID
NCT05166967
Treatments Being Tested
RATIONALE: Monoclonal antibodies such as rituximab can locate tumor cells a...
Status
Completed
Location
Naval Medical Center - San Diego
Start Date
2002-05
Trial ID
NCT00039130
This is a randomized, open-label, prospective, multicenter phase III superi...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center,
Start Date
2026-08-11
Trial ID
NCT07678229
This is a prospective, open-label , multicenter randomized controlled trial...
Status
Unknown
Location
Multiple Locations
Start Date
2019-10-15
Trial ID
NCT04131231
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
This single arm study will evaluate the efficacy and safety of MabThera in ...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00462345
Treatments Being Tested